Therapeutic protein, semisolid dosage forms and dermatopharmaceuticals
Michniak, B.B.
Idrugs the Investigational Drugs Journal 2(1): 29-30
1999
ISSN/ISBN: 1369-7056 PMID: 16180165 Document Number: 505626
Document emailed within 1 workday
Related Documents
Popkov, V.A.; Skovpen', I.V.; Reshetniak, V.I. 2001: Prospects of using hard dispersions in development of dosage forms for therapeutic and prophylactic use Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 46-48Willems, P.; Sørensen, E.W.; Hansen, T.S.; Byg, R. 1988: Drugs--dosage forms Sygeplejersken 88(31): 4-7
Helliwell, M.; Taylor, D. 1993: Solid oral dosage forms Professional Nurse 8(5): 313-317
Sobiczewska, M.; Borkowski, B. 1970: Determination of ajmaline in dosage forms Die Pharmazie 25(5): 334-335
Ritschel, W.A. 1973: Bioavailability of peroral dosage forms Bollettino Chimico Farmaceutico 112(3): 137-162
Feldmann, E.G. 1986: Modified-release dosage forms American Journal of Hospital Pharmacy 43(10): 2565-2566
Zecca, L.; Ferrario, P.; Pirola, R.; Reina, L.; Zambotti, F.; Zonta, N.; Lepore, A.M.; Scaglione, F.; Fraschini, F. 1989: Pharmacokinetics of buflomedil after various dosage forms Arzneimittel-Forschung 39(4): 518-519
Lintz, W.; Hirsch, I.; Osterloh, G.; Schmidt-Böthelt, E.; Sous, H. 1984: Bioavailability of penicillin V in aqueous dosage forms Arzneimittel-Forschung 34(1): 66-71
Voigt, R.; Bornschein, M.; Grohmann, A. 1982: Storage stability of rectal dosage forms Die Pharmazie 37(7): 529-536
Cid, E.; Morán, I.; Rodríguez, A.; Monaris, M.; Vidal, V. 1982: Evaluation of the absorption of various primidone dosage forms in man Therapie 37(5): 567-571
Zivanov-Stakić, D.; Agbaba, D.; Vladimirov, S.; Cirić, L.J. 1992: Spectrophotometric determination of diltiazem in dosage forms Farmaco 47(3): 393-396
Koget, T.O. 1970: Quantitative determination of quercetin in some dosage forms Farmatsevtychnyi Zhurnal 25(3): 79-81
Berezovskaia, L.N.; Griaznova, N.S.; Bairamashvili, D.I.; Iarotskiĭ, S.V. 1990: Problems of the development of liposomal dosage forms of antibiotics Antibiotiki i Khimioterapiia 35(10): 31-35
Abebe, A.; Chulia, D.; Verain, A. 1991: The biodisposition of paracetamol. I. the kinetics of disintegration of some dosage forms Pharmaceutica Acta Helvetiae 66(2): 56-59
Chilamkurti, R.N. 1992: Formulation development of frozen parenteral dosage forms Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(4): 124-129
Goldberg, R.; Nightingale, C.H. 1977: Stability of aspirin in propoxyphene compound dosage forms American Journal of Hospital Pharmacy 34(3): 267-269
Rak, J.; Hároníková, K. 1980: Worldwide aspects of teaching the subject, "dosage forms" Ceskoslovenska Farmacie 29(10): 329-331
Rees, J.E. 1977: "in vitro" dissolution tests for solid oral dosage forms Bollettino Chimico Farmaceutico 116(9): 499-505
Bořilová Linhartová, P.; Izakovičová Hollá, L. 2017: Drugs and dosage forms as risk factors for dental caries Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 66(3): 103-106
Akers, M.J. 2017: Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms International Journal of Pharmaceutical Compounding 21(1): 47-56